Literature DB >> 18022844

Abnormal diffusion tensor in nonsymptomatic familial amyotrophic lateral sclerosis with a causative superoxide dismutase 1 mutation.

Man-Cheuk Ng1, Jenny Ting Ho, Shu-Leong Ho, Raymand Lee, Geng Li, Tat-Sun Cheng, You-Qiang Song, Philip Wing-Lok Ho, Gardian Chung-Yan Fong, Windsor Mak, Koon-Ho Chan, Leonard Sheung-Wai Li, Keith Dip-Kei Luk, Yong Hu, David Boyer Ramsden, Lilian Ling-Yee Leong.   

Abstract

PURPOSE: To determine whether diffusion abnormalities can be observed in nonsymptomatic family members with a known causative Cu/Zn superoxide dismutase mutation (asymptomatic familial amyotrophic lateral sclerosis; AFALS(+SOD1)) in a family with autosomal dominant familial amyotrophic lateral sclerosis (ALS) using diffusion tensor imaging (DTI).
MATERIALS AND METHODS: A total of eight AFALS(+SOD1) subjects (aged 17-43 years) were age-matched with 13 healthy controls (aged 19-45 years) without SOD1 mutations. DTI was carried out on a 1.5T scanner. The diffusion index maps derived were then normalized spatially for voxel-based analysis. region of interest (ROI)-based analysis was also carried out.
RESULTS: Our voxel-based and ROI-based analysis showed that AFALS(+SOD1) subjects have decreased fractional anisotropy (FA) (0.5401 vs. 0.5168, P < 0.05) and increased tensor trace (TT) (2.5854 x 10(-3) mm(2)/second vs. 2.6226 x 10(-3) mm(2)/second, P < 0.04) at the posterior limb of the internal capsule compared to the control subjects. Increased radial diffusivity (E((2,3)/2)) was detected on both sides (right = 0.5710 x 10(-3) mm(2)/second vs. 0.5943 x 10(-3) mm(2)/second, P < 0.05; left = 0.5666 x 10(-3) mm(2)/second vs. 0.5872 x 10(-3) mm(2)/second, P < 0.05). No significant change in axial diffusivity (E(1)) was detected.
CONCLUSION: Abnormal diffusivity was found at the posterior limb of the internal capsule in AFALS(+SOD1) subjects, hitherto unreported. Our results suggest that DTI may detect diffusion abnormalities in AFALS(+SOD1) subjects before symptoms develop.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18022844     DOI: 10.1002/jmri.21217

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  26 in total

1.  Advances in the application of MRI to amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Michel Modo
Journal:  Expert Opin Med Diagn       Date:  2010-11

Review 2.  Toward precision medicine in amyotrophic lateral sclerosis.

Authors:  Zhang-Yu Zou; Chang-Yun Liu; Chun-Hui Che; Hua-Pin Huang
Journal:  Ann Transl Med       Date:  2016-01

3.  Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis.

Authors:  N Filippini; G Douaud; C E Mackay; S Knight; K Talbot; M R Turner
Journal:  Neurology       Date:  2010-11-02       Impact factor: 9.910

4.  Structural hallmarks of amyotrophic lateral sclerosis progression revealed by probabilistic fiber tractography.

Authors:  Robert Steinbach; Kristian Loewe; Joern Kaufmann; Judith Machts; Katja Kollewe; Susanne Petri; Reinhard Dengler; Hans-Jochen Heinze; Stefan Vielhaber; Mircea Ariel Schoenfeld; Christian Michael Stoppel
Journal:  J Neurol       Date:  2015-07-10       Impact factor: 4.849

5.  Comparing isotropic and anisotropic smoothing for voxel-based DTI analyses: A simulation study.

Authors:  Wim Van Hecke; Alexander Leemans; Steve De Backer; Ben Jeurissen; Paul M Parizel; Jan Sijbers
Journal:  Hum Brain Mapp       Date:  2010-01       Impact factor: 5.038

Review 6.  Defining pre-symptomatic amyotrophic lateral sclerosis.

Authors:  Michael Benatar; Martin R Turner; Joanne Wuu
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2019-03-20       Impact factor: 4.092

Review 7.  Presymptomatic studies in ALS: rationale, challenges, and approach.

Authors:  Michael Benatar; Joanne Wuu
Journal:  Neurology       Date:  2012-10-16       Impact factor: 9.910

8.  Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS.

Authors:  J D Carew; G Nair; P M Andersen; J Wuu; S Gronka; X Hu; M Benatar
Journal:  Neurology       Date:  2011-09-21       Impact factor: 9.910

Review 9.  Neuroimaging in genetic frontotemporal dementia and amyotrophic lateral sclerosis.

Authors:  Suvi Häkkinen; Stephanie A Chu; Suzee E Lee
Journal:  Neurobiol Dis       Date:  2020-09-02       Impact factor: 5.996

10.  A dual DTI approach to analyzing white matter in children with dyslexia.

Authors:  John C Carter; Diane C Lanham; Laurie E Cutting; Amy M Clements-Stephens; Xuejing Chen; Muhamed Hadzipasic; Joon Kim; Martha B Denckla; Walter E Kaufmann
Journal:  Psychiatry Res       Date:  2009-04-05       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.